# TVM Capital Healthcare

> TVM Capital Healthcare is a VC fund in Dubai backing Health Care and Medical. See 16 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Dubai, United Arab Emirates
- Total investments: 16
- Last investment: Jul 2025
- Lead investor: 56%
- Last fund: Sep 2025
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/tvmcapitalhealthcare/
- X (Twitter): https://www.twitter.com/tvmcapitalmena
- Website: https://www.tvmcapitalhealthcare.com/
- Facebook: https://www.facebook.com/633725056754327

TVM Capital Healthcare is a highly focused private equity and growth capital firm.

## Contacts

5 contacts available for TVM Capital Healthcare. Shizune tracks 9 team members at TVM Capital Healthcare. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/tvm-capital-healthcare?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series B | $40M–$124M |
| Private Equity | $11M–$35M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 9 | 56% |
| Medical | 5 | 31% |
| Biotechnology | 2 | 13% |
| Medical Device | 2 | 13% |
| Rehabilitation | 2 | 13% |

16 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Private Equity | 8 | 50% |
| Series B | 2 | 13% |
| Series A | 1 | 6% |
| Funding Round | 1 | 6% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Arab Emirates | 3 | 19% |
| United States | 2 | 13% |
| Egypt | 1 | 6% |
| Germany | 1 | 6% |
| Singapore | 1 | 6% |

8 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Farid Fezou | Managing Partner | 8 | https://shizune.co/investors/profile/farid-fezou |
| Farid Fezoua | Managing Partner | 0 | https://shizune.co/investors/profile/farid-fezoua-433e |
| Helmut M. Schühsler | Chairman and CEO | 4 | https://shizune.co/investors/profile/helmut-m-schhsler |
| Hoda Abou-Jamra | Founding Partner | 0 | https://shizune.co/investors/profile/hoda-abou-jamra |
| Orhan Osmansoy | Operating Partner | 2 | https://shizune.co/investors/profile/orhan-osmansoy |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Baraya Extended Care | Baraya is a company specializing in rehabilitation treatment, committed to providing high-quality rehabilitation treatment services to patients. | $124M | Series B | Jul 15, 2025 |  |
| Baraya Extended Care | Baraya is a company specializing in rehabilitation treatment, committed to providing high-quality rehabilitation treatment services to patients. | $124M | Series B | Jul 15, 2025 |  |
| neurocare group | Neurocare group provides mental health and performance by personalizing therapy following a detailed assessment. | $20.1M | Private Equity | Feb 05, 2025 |  |
| DEBx Medical | DEBx Medical is a MedTech company that delivers affordable treatments for people suffering from chronic wounds. |  | Private Equity | Nov 13, 2024 |  |
| Human Longevity | Human Longevity (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. Its business areas include the HLI Health Nucleus, a genomicpowered clinical research center that uses whole-genome sequence analysis, advanced clinical imaging, and innovative machine learning, along with curated personal health information to deliver the most complete picture of individual health; HLIQ Whole Genome and HLIQ Oncology. It was founded in 2013 and is headquartered in San Diego, California. | $39.8M | Series B | Aug 21, 2024 |  |
| Boston Oncology | At Boston Oncology, we support the healthcare of citizens in emerging markets around the world through regional development and production of licensed biopharmaceutical products. | $35M | Private Equity | Jun 26, 2024 |  |
| Boston Oncology | At Boston Oncology, we support the healthcare of citizens in emerging markets around the world through regional development and production of licensed biopharmaceutical products. | $35M | Private Equity | Jun 26, 2024 |  |
| neurocare group | Neurocare group provides mental health and performance by personalizing therapy following a detailed assessment. | $17.1M | Private Equity | Apr 24, 2024 |  |
| DEBx Medical | DEBx Medical is a MedTech company that delivers affordable treatments for people suffering from chronic wounds. | $11M |  | May 22, 2023 |  |
| DEBx Medical | DEBx Medical is a MedTech company that delivers affordable treatments for people suffering from chronic wounds. | $10.8M | Private Equity | May 22, 2023 |  |

10 of 16 investments shown.

## Co-investors
- [ANB Capital](https://shizune.co/investors/profile/anb-capital-df83) — VC Fund, 2 deals together
- [Olayan Financing Company](https://shizune.co/investors/profile/olayan-financing-company) — VC Fund, 2 deals together
- [Saudi Venture Capital Company](https://shizune.co/investors/profile/saudi-venture-capital-company) — VC Fund, 2 deals together
- [SEDCO Holding](https://shizune.co/investors/profile/sedco-holding) — VC Fund, 2 deals together
- [Blue7](https://shizune.co/investors/profile/blue7) — VC Fund, 1 deal together
- [Capital Code](https://shizune.co/investors/profile/capital-code) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund

### Similar stage
- [Foresight Group](https://shizune.co/investors/profile/foresight-group) — VC Fund
- [YFM Equity Partners](https://shizune.co/investors/profile/yfm-equity-partners) — VC Fund
- [Fondaction](https://shizune.co/investors/profile/fondaction) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Seeds Capital](https://shizune.co/investors/profile/seeds-capital) — VC Fund
- [Wavemaker Ventures](https://shizune.co/investors/profile/wavemaker-partners) — VC Fund

## Featured in investor lists
- [Wellness Investors in Singapore](https://shizune.co/investors/wellness-investors-singapore)
- [Wellness VC Funds in Singapore](https://shizune.co/investors/wellness-vc-funds-singapore)
- [Sports Investors in Singapore](https://shizune.co/investors/sports-investors-singapore)
- [Sports VC Funds in Singapore](https://shizune.co/investors/sports-vc-funds-singapore)
- [Fitness Investors in Singapore](https://shizune.co/investors/fitness-investors-singapore)
- [Fitness VC Funds in Singapore](https://shizune.co/investors/fitness-vc-funds-singapore)

## FAQ

### What does TVM Capital Healthcare invest in?

TVM Capital Healthcare invests primarily in Health Care, Medical and Biotechnology startups, most often at Private Equity and Series B stage. Most of the 16 investments tracked by Shizune back companies in United Arab Emirates. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is TVM Capital Healthcare's check size?

TVM Capital Healthcare typically joins rounds of $40M–$124M at Series B and $11M–$35M at Private Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds TVM Capital Healthcare participates in.

### How do I contact TVM Capital Healthcare?

Public channels for TVM Capital Healthcare include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at TVM Capital Healthcare?

The team at TVM Capital Healthcare includes Farid Fezou (Managing Partner), Farid Fezoua (Managing Partner) and Helmut M. Schühsler (Chairman and CEO), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co